While current economic conditions continue to restrain market growth, the U.S. market for minimally invasive bariatric surgical devices is expected to exhibit relatively strong growth over the next 5 years. Valued at more than $345 million in 2010, the U.S. minimally invasive bariatric surgical products market is expected to increase at a healthy compound annual rate of 6.6%, with sales reaching more than $500 million in 2016.
The market is expected to benefit from increased utilization of laparoscopic adjustable gastric banding systems and emerging incisionless technologies, including intragastric balloons and other transorally inserted weight loss devices, as well as implantable gastric stimulators or vagal blocking systems. The market is also expected to benefit from growing usage of single-incision surgery; minimally invasive robotic surgery is also expected to continue to significantly improve bariatric surgical outcomes.
This dynamic report from Medtech Insight includes analyses of products, markets, competitors, and emerging technology and opportunities. Covered topics in this report include laparoscopic adjustable gastric banding (LAGB) systems; intragastric balloon systems; emerging transorally inserted weight loss devices; single-incision technologies; minimally invasive robotic systems; and implantable gastric stimulation/vagal blocking systems.
EXECUTIVE SUMMARY i. Causes of Obesity ii. Health Risks iii. Statistics iv. Minimally Invasive Bariatric Surgical Devices Market v. Methodology Exhibit ES-1: Body Mass Index and Obesity Exhibit ES-2: Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity Exhibit ES-3: Trends in Overweight, Obesity, and Morbid Obesity, 1988-2008 Exhibit ES-4: Trends in Overweight, Obesity, and Morbid Obesity, 1960-2008 Exhibit ES-5: Prevalence of Obesity Among Men, by Race/Ethnicity, 1988-1994 and 2007-2008 Exhibit ES-6: Prevalence of Obesity Among Women, by Race/Ethnicity, 1988-1994 and 2007-2008 Exhibit ES-7: Minimally Invasive Bariatric Surgery, Procedure Volumes Forecast, 2010-2016 Exhibit ES-8: Minimally Invasive Bariatric Surgical Devices, Combined Market Forecast, by Segment, 2010-2016 1. CLINICAL OVERVIEW OF OBESITY 1.1 Causes of Obesity 1.1.1 Calorie Intake 1.1.2 Genetics 1.1.3 Behavior and Environment 1.1.4 Diseases/Disorders and Drug Use 1.2 Health Risks 1.2.1 Diabetes 1.2.2 Cancer 1.3 Statistics Exhibit 1-1: Body Mass Index and Obesity Exhibit 1-2: Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity Exhibit 1-3: Comorbidities of Obesity Exhibit 1-4: Trends in Overweight, Obesity, and Morbid Obesity, 1988-2008 Exhibit 1-5: Trends in Overweight, Obesity, and Morbid Obesity, 1960-2008 Exhibit 1-6: Prevalence of Obesity Among Men, by Race/Ethnicity, 1988-1994 and 2007-2008 Exhibit 1-7: Prevalence of Obesity Among Women, by Race/Ethnicity, 1988-1994 and 2007-2008 Exhibit 1-8: 2007, Prevalence of Obesity Among Adults, by State 2. GASTRIC BANDING AND INTRAGASTRIC BALLOON SYSTEMS 2.1 Laparoscopic Adjustable Gastric Banding 2.1.1 Allergan 2.1.2 Ethicon Endo-Surgery/Johnson & Johnson 2.1.3 Others 184.108.40.206 Agency for Medical Innovations 220.127.116.11 Cousin Biotech 18.104.22.168 Helioscopie 22.214.171.124 Medical Innovation Developpement 2.2 Intragastric Balloons 2.2.1 Allergan 2.2.2 Helioscopie 2.2.3 Reshape Medical 2.2.4 Spatz FGIA 2.3 Market Analysis, Laparoscopic Adjustable Gastric Banding 2.3.1 Procedure Volumes Forecast 2.3.2 Market Forecast 126.96.36.199 Market Drivers 188.8.131.52 Market Limiters 2.3.3 Competitive Analysis 2.4 Market Analysis, Intragastric Balloon Systems Exhibit 2-1: Risks Associated with Gastric Banding and Abdominal/Bariatric Surgery Exhibit 2-2: 2011, Selected Laparoscopic Adjustable Gastric Banding Devices Exhibit 2-3: Allergan's LAP-BAND AP Adjustable Gastric Banding System Exhibit 2-4: Key Benefits and Risks of the LAP-BAND Procedure Exhibit 2-5: Excess Weight Loss with the LAP-BAND System Compared to Roux-en-Y Gastric Bypass at Three Years and Beyond Exhibit 2-6: Allergan's EasyBand Remote Adjustable Gastric Band System Exhibit 2-7: Ethicon Endo-Surgery's Realize Adjustable Gastric Band Exhibit 2-8: Pressure Comparison of the Realize Band Balloon with the LAP-BAND System Exhibit 2-9: Comparison of Gastric Banding, Gastric Bypass, and Sleeve Gastrectomy Exhibit 2-10: Effects of the Realize Adjustable Gastric Banding on Obesity-Related Conditions Exhibit 2-11: Ethicon Endo-Surgery's Realize Band-C Adjustable Gastric Band Exhibit 2-12: Agency for Medical Innovations' Soft Gastric Band Exhibit 2-13: Cousin Biotech's Bioring Adjustable Gastric Band Exhibit 2-14: Helioscopie's Heliogast Adjustable Gastric Band Exhibit 2-15: Medical Innovation Developpement's MIDBAND Adjustable Gastric Band Exhibit 2-16: Allergan's Orbera Managed Weight Loss System Exhibit 2-17: Helioscopie's Heliosphere Intragastric Balloon Exhibit 2-18: ReShape Duo Intragastric Balloon System Exhibit 2-19: The Spatz Adjustable Balloon System Exhibit 2-20: Risks of Intragastric Balloon Placement Exhibit 2-21: The Spatz Adjustable Balloon Procedure Exhibit 2-22: Laparoscopic Adjustable Gastric Banding, Procedure Volumes Forecast, 2010-2016 Exhibit 2-23: Laparoscopic Adjustable Gastric Banding, Market Forecast, 2010-2016 Exhibit 2-24: 2010, Laparoscopic Adjustable Gastric Banding Systems Market, Share by Supplier Exhibit 2-25: Intragastric Balloon Therapy, Procedure Volumes Forecast, 2010-2016 Exhibit 2-26: Intragastric Balloon Systems, Market Forecast, 2010-2016 3. TRANSORAL INCISIONLESS WEIGHT LOSS TECHNOLOGIES AND DEVICES 3.1 Selected Products 3.1.1 EndoGastric Solutions 3.1.2 GI Dynamics 3.1.3 Satiety 3.1.4 USGI Medical Exhibit 3-1: Emerging Trends in Minimally Invasive/Incisionless Surgery Exhibit 3-2: EndoGastric Solutions' StomaphyX Transoral Fastener Delivery System Exhibit 3-3: GI Dynamic's EndoBarrier Gastrointestinal Liner and Procedure Exhibit 3-4: GI Dynamic's EndoBarrier Gastrointestinal Liner Combined with the EndoBarrier Flow Restrictor Exhibit 3-5: Steps of a Transoral Gastroplasty (or TOGA) Procedure Exhibit 3-6: USGI Medical's Incisionless Operating Platform Exhibit 3-7: Primary Obesity Surgery, Endolumenal and Repair of Surgery, Endolumenal 4. SINGLE-PORT ACCESS SURGERY 4.1 Single-Incision Bariatric Surgery 4.2 Natural Orifice Transluminal Endoscopic Surgery 4.3 Procedure Volumes 4.4 Patient Outcomes 4.5 Economics and Consumer Demand 4.6 Selected Products 4.6.1 Applied Medical Resources 4.6.2 Covidien 4.6.3 Ethicon Endo-Surgery/Johnson & Johnson 4.6.4 Olympus America/Olympus and Advanced Surgical Concepts 4.6.5 TransEnterix 4.6.6 USGI Medical Exhibit 4-1: Selected Advantages of Single-Port Access Surgery Exhibit 4-2: Procedures Employing Single-Port Access Exhibit 4-3: Selected Laparoscopic Procedures that Could Benefit from the Use of Single-Port Access, Procedure Volumes Forecast, 2010-2016 Exhibit 4-4: Factors Impacting the Adoption of Single-Port Access Surgery Exhibit 4-5: Applied Medical Resources' GelPOINT Advanced Access Platform Exhibit 4-6: Applied Medical Resources' Premium Disposable Trocar, Kii GelPort Balloon Trocar, and Universal Seal Exhibit 4-7: Covidien's SILS Port Exhibit 4-8: Covidien's SILS Stitch Articulating Suturing Device Exhibit 4-9: Ethicon Endo-Surgery's ENDOPATH XCEL Bladeless Trocar Exhibit 4-10: Ethicon Endo-Surgery's Single-Site Laparoscopy Access System Exhibit 4-11: Olympus America's Deflectable-Tip EndoEYE Video Laparoscope Exhibit 4-12: Advanced Surgical Concepts' TriPort Multiport Access Device Exhibit 4-13: Advanced Surgical Concepts' QuadPort Multiport Access Device Exhibit 4-14: TransEnterix's SPIDER Surgical System Exhibit 4-15: USGI Medical's Incisionless Operating Platform 5. ROBOTIC-ASSISTED MINIMALLY INVASIVE SURGERY 5.1 Intuitive Surgical 5.1.1 The da Vinci Surgical System 184.108.40.206 The Da Vinci Gastric Bypass 5.1.2 Robotic-Assisted Minimally Invasive Surgery, Market Analysis Exhibit 5-1: Selected Procedures Facilitated by the da Vinci Surgical System Exhibit 5-2: Intuitive Surgical's da Vinci S HD Surgical System Exhibit 5-3: Intuitive Surgical's da Vinci Si HD Surgical System Exhibit 5-4: Intuitive Surgical's EndoWrist Instrument Exhibit 5-5: Comparison of the da Vinci Gastric Bypass Procedure with the Open Surgical Technique Exhibit 5-6: Intuitive Surgical's Revenues and Unit Sales, 2009 and 2010 Exhibit 5-7: Procedures that Employ Intuitive Surgical's da Vinci Surgical System Exhibit 5-8: Targeted Procedures for which the da Vinci Surgical System May Be Employed Exhibit 5-9: Robotic-Assisted Minimally Invasive Surgical Systems, Market Forecast, 2010-2016 6. IMPLANTABLE GASTRIC STIMULATION DEVICES 6.1 Selected Products 6.1.1 EnteroMedics 6.1.2 IntraPace 6.1.3 MetaCure 6.1.4 Others 220.127.116.11 Cyberonics and Ethicon Endo-Surgery/Johnson & Johnson 18.104.22.168 Leptos Biomedical 22.214.171.124 Medtronic 126.96.36.199 St. Jude Medical 6.2 Market Analysis Exhibit 6-1: 2011, Selected Emerging Implantable Pulse Generators for the Treatment of Obesity Exhibit 6-2: EnteroMedics' Maestro System Exhibit 6-3: Overview of EnteroMedics' VBLOC Therapy and Vagus Nerve Function Exhibit 6-4: Potential Benefits and Risks of VBLOC Therapy Exhibit 6-5: Comparison of VBLOC Therapy, Laparoscopic Banding, and Gastric Bypass Exhibit 6-6: EMPOWER Study, 24-Month Weight Loss Results Exhibit 6-7: VBLOC-DM2 Study, 12-Month Weight Loss Results Exhibit 6-8: VBLOC RF2 Study, 24-Month Weight Loss Results Exhibit 6-9: IntraPace's abiliti Gastric Stimulation System Exhibit 6-10: MetaCure's TANTALUS Gastric Stimulation System Exhibit 6-11: Medtronic's Enterra Neurostimulator Exhibit 6-12: St. Jude Medical's Eon Mini Neurostimulator Exhibit 6-13: Implantable Gastric Stimulation/VBLOC Therapy Devices, Unit Sales Forecast, 2010-2016 Exhibit 6-14: Implantable Gastric Stimulation/VBLOC Therapy Devices, Market Forecast, 2010-2016 7. COMPANY PROFILES 7.1 Allergan, Inc. 7.2 Covidien PLC 7.3 EndoGastric Solutions, Inc. 7.4 EnteroMedics, Inc. 7.5 GI Dynamics, Inc. 7.6 Intuitive Surgical, Inc. 7.7 Johnson & Johnson 7.8 ReShape Medical, Inc. 7.9 Satiety, Inc. 7.10 Spatz FGIA, Inc. 7.11 TransEnterix, Inc. 7.12 USGI Medical, Inc. APPENDIX: COMPANY LISTING